BR9907256A - Inibidores beta-cetoamida de proteassoma 20s - Google Patents
Inibidores beta-cetoamida de proteassoma 20sInfo
- Publication number
- BR9907256A BR9907256A BR9907256-4A BR9907256A BR9907256A BR 9907256 A BR9907256 A BR 9907256A BR 9907256 A BR9907256 A BR 9907256A BR 9907256 A BR9907256 A BR 9907256A
- Authority
- BR
- Brazil
- Prior art keywords
- proteasome
- beta
- ketoamide
- inhibitors
- ketoamide inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/013,365 US6075150A (en) | 1998-01-26 | 1998-01-26 | α-ketoamide inhibitors of 20S proteasome |
PCT/US1999/001097 WO1999037666A1 (en) | 1998-01-26 | 1999-01-19 | α-KETOAMIDE INHIBITORS OF 20S PROTEASOME |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9907256A true BR9907256A (pt) | 2001-10-09 |
Family
ID=21759598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9907256-4A BR9907256A (pt) | 1998-01-26 | 1999-01-19 | Inibidores beta-cetoamida de proteassoma 20s |
Country Status (20)
Country | Link |
---|---|
US (2) | US6075150A (pt) |
EP (1) | EP1058689A1 (pt) |
JP (1) | JP3863370B2 (pt) |
KR (1) | KR100417888B1 (pt) |
CN (1) | CN1289340A (pt) |
AR (1) | AR012781A1 (pt) |
AU (1) | AU747835B2 (pt) |
BR (1) | BR9907256A (pt) |
CA (1) | CA2319150C (pt) |
GE (1) | GEP20032869B (pt) |
HU (1) | HUP0100901A3 (pt) |
IL (2) | IL137475A0 (pt) |
NO (1) | NO327049B1 (pt) |
NZ (1) | NZ505892A (pt) |
PL (1) | PL202504B1 (pt) |
RU (1) | RU2192429C2 (pt) |
TW (1) | TW593339B (pt) |
UA (1) | UA71559C2 (pt) |
WO (1) | WO1999037666A1 (pt) |
ZA (1) | ZA99161B (pt) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050227925A1 (en) * | 2004-04-08 | 2005-10-13 | Robbert Benner | Compositions capable of reducing elevated blood urea concentration |
US20040202645A1 (en) * | 2003-04-08 | 2004-10-14 | Khan Nisar Ahmed | Administration of gene-regulatory peptides |
US6844315B2 (en) | 1998-05-20 | 2005-01-18 | Erasmus Universiteit Rotterdam | Immunoregulator |
US8680059B2 (en) * | 1998-05-20 | 2014-03-25 | Biotempt B.V. | Oligopeptide acetate and formulations thereof |
US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
US6921751B1 (en) * | 1998-05-20 | 2005-07-26 | Erasmus Universiteit Rotterdam | Immunoregulator |
US6902721B1 (en) * | 1998-07-10 | 2005-06-07 | Osteoscreen, Inc. | Inhibitors of proteasomal activity for stimulating bone growth |
US7358330B2 (en) | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
EP1300418A1 (en) * | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Gene regulation by oligopeptides |
US6949567B2 (en) | 2001-02-26 | 2005-09-27 | 4Sc Ag | Compounds for the treatment of protozoal diseases |
US7786084B2 (en) * | 2001-12-21 | 2010-08-31 | Biotempt B.V. | Treatment of burns |
US7560433B2 (en) | 2001-12-21 | 2009-07-14 | Biotempt B.V. | Treatment of multiple sclerosis (MS) |
US7501391B2 (en) * | 2001-12-21 | 2009-03-10 | Biotempt B.V. | Treatment of transplant survival |
US20080242837A1 (en) * | 2001-12-21 | 2008-10-02 | Khan Nisar A | Peptide compositions |
US20040013661A1 (en) * | 2001-12-21 | 2004-01-22 | Gert Wensvoort | Stratification |
US20030220260A1 (en) * | 2001-12-21 | 2003-11-27 | Khan Nisar Ahmed | Peptide compositions |
US20030220257A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of trauma |
US20080318871A1 (en) * | 2001-12-21 | 2008-12-25 | Khan Nisar A | Treatment of neurological disorders |
US20030220261A1 (en) * | 2001-12-21 | 2003-11-27 | Khan Nisar Ahmed | Treatment of iatrogenic disease |
EP1465862A1 (en) | 2002-01-17 | 2004-10-13 | SmithKline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
NZ561851A (en) | 2002-04-11 | 2009-05-31 | Vertex Pharma | Inhibitors of serine proteases, particularly hepatitis C virus NS3 - NS4 protease |
US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7223745B2 (en) * | 2003-08-14 | 2007-05-29 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
TW201127828A (en) | 2003-09-05 | 2011-08-16 | Vertex Pharma | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
EP1637529A1 (en) * | 2004-09-20 | 2006-03-22 | 4Sc Ag | Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof |
US7468383B2 (en) * | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
WO2006124494A1 (en) * | 2005-05-13 | 2006-11-23 | Virginia Tech Intellectual Properties, Inc. | TRANSITION-STATE INHIBITORS OF PIN1, α-KETOAMIDE-CONTAINING PEPTIDOMIMETICS, AND SYNTHESES THEREOF |
JP4846799B2 (ja) * | 2005-07-05 | 2011-12-28 | バイオテンプト ベー.フェー. | 腫瘍の治療 |
TW200745061A (en) | 2005-07-29 | 2007-12-16 | Tibotec Pharm Ltd | Macrocylic inhibitors of hepatitis C virus |
MX2008001402A (es) | 2005-07-29 | 2008-04-04 | Tibotec Pharm Ltd | Inhibidores macrociclicos del virus de la hepatitis c. |
CN105237621A (zh) | 2005-11-09 | 2016-01-13 | 欧尼斯治疗公司 | 用于酶抑制的化合物 |
US8594771B2 (en) * | 2005-12-28 | 2013-11-26 | General Electric Company | Devices and methods for self-administered ECG examinations |
EP1864692A1 (en) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
EP2041158B1 (en) | 2006-06-19 | 2013-04-17 | Onyx Therapeutics, Inc. | Peptide epoxyketones for proteasome inhibition |
SG178780A1 (en) * | 2007-02-12 | 2012-03-29 | Biotempt Bv | Treatment of trauma-hemorrhage with short oligopeptides |
US8859021B2 (en) * | 2007-05-14 | 2014-10-14 | Sytheon | Skin appearance through gene manipulation |
US7442830B1 (en) | 2007-08-06 | 2008-10-28 | Millenium Pharmaceuticals, Inc. | Proteasome inhibitors |
CL2008002966A1 (es) | 2007-10-04 | 2010-06-25 | Onyx Therapeutics Inc | Compuesto tetrapeptido ceto-epoxido cristalino; sal citrato cristalina del compuesto; metodos de preparacion; compuesto intermediario cristalino; metodo de preparacion; y uso para tratar cancer, enfermedad autoinmune, afeccion relacionada con trasplante, enfermedad neurodegenerativa, afeccion asociada con fibrosis, entre otros. |
MX349769B (es) | 2008-06-17 | 2017-08-11 | Millennium Pharm Inc | Compuestos de éster boronato y composiciones farmacéuticas de los mismos. |
EA035100B1 (ru) | 2008-10-21 | 2020-04-28 | Оникс Терапьютикс, Инк. | Комбинированная терапия с применением пептид эпоксикетонов |
EP3021120A1 (en) | 2009-02-20 | 2016-05-18 | Michael P. Lisanti | Diagnosis, prognosis, therapeutics and methods for treating neoplastic deiseases comprising determining the level of caveolin-1 in a stromal cell sample |
TWI504598B (zh) | 2009-03-20 | 2015-10-21 | Onyx Therapeutics Inc | 結晶性三肽環氧酮蛋白酶抑制劑 |
WO2011060179A1 (en) | 2009-11-13 | 2011-05-19 | Onyx Therapeutics, Inc | Use of peptide epoxyketones for metastasis suppression |
CN102725300B (zh) | 2009-12-22 | 2015-03-11 | 赛福伦公司 | 蛋白酶体抑制剂及其制备、纯化、和应用的方法 |
US9359398B2 (en) | 2010-03-01 | 2016-06-07 | Onyx Therapeutics, Inc. | Compounds for immunoproteasome inhibition |
BR112012025264A2 (pt) | 2010-04-07 | 2019-09-24 | Onyx Therapeutics Inc | inibidor de imunoproteassoma de e´poxicetona peptídica cristalina. |
JP6002222B2 (ja) | 2011-08-11 | 2016-10-05 | ヤンセン ファーマシューティカ エヌ.ベー. | がん治療用予測因子 |
EP2771489B1 (en) | 2011-10-28 | 2018-07-04 | Millennium Pharmaceuticals, Inc. | Biomarkers of response to nae inhibitors |
JP6286358B2 (ja) | 2011-11-11 | 2018-02-28 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | プロテアソーム阻害剤に応答するバイオマーカー |
EP2810066B1 (en) | 2012-01-24 | 2019-07-31 | Millennium Pharmaceuticals, Inc. | Methods of treatment of cancer |
GB2523211B (en) | 2012-01-27 | 2020-03-18 | Univ Jefferson | MCT protein inhibitor-related prognostic and therapeutic methods |
UY34897A (es) | 2012-07-09 | 2014-01-31 | Onyx Therapeutics Inc | Profarmacos de inhibidores peptidicos de expoxi cetona proteasa |
CA2886783A1 (en) | 2012-10-01 | 2014-04-10 | Millennium Pharmaceuticals, Inc. | Biomarkers and methods to predict response to inhibitors and uses thereof |
EP2906581A1 (en) * | 2012-10-11 | 2015-08-19 | F. Hoffmann-La Roche AG | Ketoamide immunoproteasome inhibitors |
US10022372B2 (en) | 2013-04-19 | 2018-07-17 | Thomas Jefferson University | Caveolin-1 related methods for treating glioblastoma with temozolomide |
JP2017524652A (ja) | 2014-05-20 | 2017-08-31 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | 一次癌療法後に使用するためのホウ素含有プロテアソーム阻害剤 |
JP6859559B2 (ja) * | 2017-03-16 | 2021-04-14 | 二村 芳弘 | 抗アレルギー作用を呈するフェニルペプチド誘導体 |
WO2019044736A1 (ja) * | 2017-08-28 | 2019-03-07 | 静岡県公立大学法人 | コリバクチンおよびコリバクチン産生菌の検出方法および検出プローブ |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1206078B (it) * | 1987-06-03 | 1989-04-14 | Polifarma Spa | Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico |
JPH04211648A (ja) * | 1990-07-27 | 1992-08-03 | Nippon Kayaku Co Ltd | ケト酸アミド誘導体 |
US5430022A (en) * | 1990-05-14 | 1995-07-04 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compound and its preparation |
US5693617A (en) * | 1994-03-15 | 1997-12-02 | Proscript, Inc. | Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein |
US6660268B1 (en) * | 1994-03-18 | 2003-12-09 | The President And Fellows Of Harvard College | Proteasome regulation of NF-KB activity |
US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
US5834487A (en) * | 1996-09-24 | 1998-11-10 | Cv Therapeutics | Inhibition of 26S and 20S proteasome by indanones |
-
1998
- 1998-01-26 US US09/013,365 patent/US6075150A/en not_active Expired - Fee Related
-
1999
- 1999-01-11 ZA ZA9900161A patent/ZA99161B/xx unknown
- 1999-01-19 IL IL13747599A patent/IL137475A0/xx active IP Right Grant
- 1999-01-19 AU AU23267/99A patent/AU747835B2/en not_active Ceased
- 1999-01-19 EP EP99903185A patent/EP1058689A1/en not_active Ceased
- 1999-01-19 KR KR10-2000-7008135A patent/KR100417888B1/ko not_active IP Right Cessation
- 1999-01-19 RU RU2000122474/04A patent/RU2192429C2/ru not_active IP Right Cessation
- 1999-01-19 WO PCT/US1999/001097 patent/WO1999037666A1/en active IP Right Grant
- 1999-01-19 CN CN99802421A patent/CN1289340A/zh active Pending
- 1999-01-19 PL PL343269A patent/PL202504B1/pl not_active IP Right Cessation
- 1999-01-19 UA UA2000074508A patent/UA71559C2/uk unknown
- 1999-01-19 HU HU0100901A patent/HUP0100901A3/hu unknown
- 1999-01-19 NZ NZ505892A patent/NZ505892A/xx unknown
- 1999-01-19 JP JP2000528587A patent/JP3863370B2/ja not_active Expired - Fee Related
- 1999-01-19 CA CA002319150A patent/CA2319150C/en not_active Expired - Fee Related
- 1999-01-19 BR BR9907256-4A patent/BR9907256A/pt not_active Application Discontinuation
- 1999-01-19 GE GEAP19995526A patent/GEP20032869B/en unknown
- 1999-01-20 AR ARP990100205A patent/AR012781A1/es active IP Right Grant
- 1999-01-22 TW TW088101002A patent/TW593339B/zh not_active IP Right Cessation
- 1999-07-19 US US09/356,842 patent/US6781000B1/en not_active Expired - Fee Related
-
2000
- 2000-07-24 IL IL137475A patent/IL137475A/en not_active IP Right Cessation
- 2000-07-25 NO NO20003807A patent/NO327049B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US6075150A (en) | 2000-06-13 |
KR100417888B1 (ko) | 2004-02-11 |
NZ505892A (en) | 2002-10-25 |
CN1289340A (zh) | 2001-03-28 |
PL202504B1 (pl) | 2009-06-30 |
NO20003807D0 (no) | 2000-07-25 |
AU2326799A (en) | 1999-08-09 |
ZA99161B (en) | 1999-07-28 |
NO327049B1 (no) | 2009-04-14 |
UA71559C2 (en) | 2004-12-15 |
JP3863370B2 (ja) | 2006-12-27 |
WO1999037666A1 (en) | 1999-07-29 |
CA2319150A1 (en) | 1999-07-29 |
PL343269A1 (en) | 2001-08-13 |
US6781000B1 (en) | 2004-08-24 |
GEP20032869B (en) | 2003-01-27 |
HUP0100901A3 (en) | 2001-11-28 |
HUP0100901A2 (hu) | 2001-08-28 |
TW593339B (en) | 2004-06-21 |
KR20010034381A (ko) | 2001-04-25 |
NO20003807L (no) | 2000-09-25 |
AR012781A1 (es) | 2000-11-08 |
RU2192429C2 (ru) | 2002-11-10 |
EP1058689A1 (en) | 2000-12-13 |
AU747835B2 (en) | 2002-05-23 |
IL137475A (en) | 2006-10-05 |
IL137475A0 (en) | 2001-07-24 |
JP2002501080A (ja) | 2002-01-15 |
CA2319150C (en) | 2004-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9907256A (pt) | Inibidores beta-cetoamida de proteassoma 20s | |
DE69933257D1 (de) | Lithographische Vorrichtung | |
BR9703302A (pt) | Aparelho e método para a geração e uso de ìons férricos | |
DE29811479U1 (de) | Plattenanordnung zur Osteosynthese | |
BR0015976A (pt) | Solvente de limpeza a seco, e, método para limpar um substrato | |
ES2184127T3 (es) | Derivados de sulfamato anticonvulsivos utiles para el tratamiento de la obesidad. | |
NO20030503L (no) | Bearbeidingsinstrument for pröveinnretninger | |
BR9906888A (pt) | "travessa" | |
DE69902077T2 (de) | Vorrichtung zur Reinigung von Wasserstoff | |
DE69931943D1 (de) | Vorrichtung für koagulationsreaktionen | |
DE29606772U1 (de) | Vorrichtung zum elektrischen Anschluß von Kühlgerätebauteilen | |
BR9813905A (pt) | Instalação para influenciar uma instalação de iluminação | |
BR9804676A (pt) | Processo para o teste de um dispositivo de embreagem automatizado. | |
DE19882984T1 (de) | Schraubenspindel für Vakuumpumpen | |
DE69930027D1 (de) | Metallisierungsverfahren für Halbleiter | |
ES2186807T3 (es) | Inhibidores de trombina. | |
DE69732302D1 (de) | Kompakte vorrichtung für beleuchtung | |
UY26574A1 (es) | " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol". | |
DE69529386D1 (de) | Verbesserungen für Halbleiteranordnungen | |
DE69940531D1 (de) | Vorrichtung für Gleichstrom-Energiespeichereinrichtung | |
DE9409045U1 (de) | Kühlkörper für Mikroprozessoren | |
BR9700040A (pt) | Máquina copiadora tendo um instrumento para remover grampo ativo | |
ES1042704Y (es) | "accesorio para cajon". | |
DE29820397U1 (de) | Bearbeitungsvorrichtung für plattenartige Werkstücke | |
DE69905697D1 (de) | Vorrichtung für walzgeräte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: NA PETICAO NO 003791 DE 21.01.2002 FOI REQUERIDO O EXAME DO PEDIDO DE PATENTE DE INVENCAO PI9907256-4 CONTENDO 28 REIVINDICACOES. VERIFICOU-SE O PAGAMENTO DA TAXA RELATIVA AO PEDIDO DE EXAME DE 28 REIVINDICACOES (FL. 110 DO PROCESSO). NO ENTANTO, O QUADRO REIVINDICATORIO (FLS. 102-106 DO PROCESSO), QUE FOI ALTERADO NA PETICAO NO049611 DE 06.12.2000, POSSUI UM TOTAL DE 29 REIVINDICACOES. A REQUERENTE DEVERA COMPLEMENTAR O VALOR DA TAXA DE EXAME REFERENTE A REIVINDICACAO EXCEDENTE, PARA QUE SE DE PROSSEGUIMENTO AO EXAME TECNICO. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 24 DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |